{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T05:27:21Z","timestamp":1778304441882,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["MAT 2014-59134-R projects"],"award-info":[{"award-number":["MAT 2014-59134-R projects"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007136","name":"Secretar\u00eda de Estado de Investigaci\u00f3n, Desarrollo e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["BES-2012-056083"],"award-info":[{"award-number":["BES-2012-056083"]}],"id":[{"id":"10.13039\/501100007136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["M-ERA-NET-0004\/2015"],"award-info":[{"award-number":["M-ERA-NET-0004\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/AGR\/04033\/2013"],"award-info":[{"award-number":["UID\/AGR\/04033\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/QUI\/50006\/2013"],"award-info":[{"award-number":["UID\/QUI\/50006\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12951-018-0356-z","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T23:58:27Z","timestamp":1522799907000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":239,"title":["Memantine loaded PLGA PEGylated nanoparticles for Alzheimer\u2019s disease: in vitro and in vivo characterization"],"prefix":"10.1186","volume":"16","author":[{"given":"Elena","family":"S\u00e1nchez-L\u00f3pez","sequence":"first","affiliation":[]},{"given":"Miren","family":"Ettcheto","sequence":"additional","affiliation":[]},{"given":"Maria Antonia","family":"Egea","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Espina","sequence":"additional","affiliation":[]},{"given":"Amanda","family":"Cano","sequence":"additional","affiliation":[]},{"given":"Ana Cristina","family":"Calpena","sequence":"additional","affiliation":[]},{"given":"Antoni","family":"Camins","sequence":"additional","affiliation":[]},{"given":"Nuria","family":"Carmona","sequence":"additional","affiliation":[]},{"given":"Am\u00e9lia M.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Eliana B.","family":"Souto","sequence":"additional","affiliation":[]},{"given":"Maria Luisa","family":"Garc\u00eda","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"issue":"7","key":"356_CR1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1517\/14656566.2014.902446","volume":"15","author":"Y Nakamura","year":"2014","unstructured":"Nakamura Y, Kitamura S, Homma A, Shiosakai K, Matsui D. Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer\u2019s disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan. Exp Opin Pharmacother. 2014;15(7):913\u201325.","journal-title":"Exp Opin Pharmacother"},{"key":"356_CR2","first-page":"1","volume":"5247","author":"I Cacciatore","year":"2016","unstructured":"Cacciatore I, Ciulla M, Fornasari E, Marinelli L, Di Stefano A. Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases. Exp Opin Drug Deliv. 2016;5247:1\u201311.","journal-title":"Exp Opin Drug Deliv"},{"issue":"1","key":"356_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0378-5173(98)00381-0","volume":"179","author":"F Gamisans","year":"1999","unstructured":"Gamisans F, Lacoulonche F, Chauvet A, Espina M, Garc\u0131\u0301a M, Egea M. Flurbiprofen-loaded nanospheres: analysis of the matrix structure by thermal methods. Int J Pharm. 1999;179(1):37\u201348.","journal-title":"Int J Pharm"},{"issue":"8","key":"356_CR4","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1023\/A:1010931127745","volume":"18","author":"P Calvo","year":"2001","unstructured":"Calvo P, Gouritin B, Angelo JD, Noel J, Georgin D, Fattal E, et al. Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharm Res. 2001;18(8):1157\u201366.","journal-title":"Pharm Res"},{"issue":"2","key":"356_CR5","first-page":"749","volume":"8","author":"Q Cai","year":"2016","unstructured":"Cai Q, Wang L, Deng G, Liu J, Chen Q, Chen Z. Systemic delivery to central nervous system by engineered PLGA nanoparticles. Am J Transl Res. 2016;8(2):749\u201364.","journal-title":"Am J Transl Res"},{"key":"356_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejps.2014.06.024","volume":"63","author":"S Jose","year":"2014","unstructured":"Jose S, Sowmya S, Cinu TA, Aleykutty NA, Thomas S, Souto EB. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A. Eur J Pharm Sci. 2014;63:29\u201335. \n                    https:\/\/doi.org\/10.1016\/j.ejps.2014.06.024\n                    \n                  .","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"356_CR7","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1002\/jbm.b.33648","volume":"105","author":"Y Xu","year":"2017","unstructured":"Xu Y, Kim CS, Saylor DM, Koo D. Polymer degradation and drug delivery in PLGA-based drug\u2014polymer applications: a review of experiments and theories. J Biomed Mater Res Part B Appl Biomater. 2017;105(6):1692\u2013716.","journal-title":"J Biomed Mater Res Part B Appl Biomater"},{"issue":"28","key":"356_CR8","doi-asserted-by":"publisher","first-page":"12076","DOI":"10.1039\/C5NR03474D","volume":"7","author":"C Fornaguera","year":"2015","unstructured":"Fornaguera C, Feiner-Gracia N, Calder\u00f3 G, Garc\u00eda-Celma MJ, Solans C. Galantamine-loaded PLGA nanoparticles, from nano-emulsion templating, as novel advanced drug delivery systems to treat neurodegenerative diseases. Nanoscale. 2015;7(28):12076\u201384.","journal-title":"Nanoscale"},{"issue":"10","key":"356_CR9","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/cas.12737","volume":"106","author":"ZJ Huo","year":"2015","unstructured":"Huo ZJ, Wang SJ, Wang ZQ, Zuo WS, Liu P, Pang B, et al. Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: therapeutic efficacy evaluation. Cancer Sci. 2015;106(10):1429\u201337.","journal-title":"Cancer Sci"},{"key":"356_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jconrel.2015.12.029","volume":"223","author":"LJ Cruz","year":"2016","unstructured":"Cruz LJ, Stammes MA, Que I, Van Beek ER, Knol-Blankevoort VT, Snoeks TJA, et al. Effect of PLGA NP size on efficiency to target traumatic brain injury. J Control Release. 2016;223:31\u201341.","journal-title":"J Control Release"},{"issue":"13","key":"356_CR11","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1517\/14656566.2014.945907","volume":"15","author":"A Kurz","year":"2014","unstructured":"Kurz A, Grimmer T. Efficacy of memantine hydrochloride once-daily in Alzheimer\u2019s disease. Exp Opin Pharmacother. 2014;15(13):1955\u201360.","journal-title":"Exp Opin Pharmacother"},{"issue":"4","key":"356_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0123289","volume":"10","author":"S Matsunaga","year":"2015","unstructured":"Matsunaga S, Kishi T, Iwata N. Memantine monotherapy for Alzheimer\u2019s disease: a systematic review and meta-analysis. PLoS ONE. 2015;10(4):1\u201316.","journal-title":"PLoS ONE"},{"key":"356_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejps.2014.04.014","volume":"60","author":"G Joshi","year":"2014","unstructured":"Joshi G, Kumar A, Sawant K. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery. Eur J Pharm Sci. 2014;60:80\u20139.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"356_CR14","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.3109\/10717544.2015.1043472","volume":"23","author":"S Zhu","year":"2016","unstructured":"Zhu S, Chen S, Gao Y, Guo F, Li F, Xie B, et al. Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide. Drug Deliv. 2016;23(6):1980\u201391.","journal-title":"Drug Deliv"},{"key":"356_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ejpb.2014.12.021","volume":"97","author":"L Inchaurraga","year":"2015","unstructured":"Inchaurraga L, Mart\u00edn-Arbella N, Zabaleta V, Quincoces G, Pe\u00f1uelas I, Irache JM. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration. Eur J Pharm Biopharm. 2015;97:280\u20139.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"356_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0168-3659(03)00273-6","volume":"91","author":"FT Meng","year":"2003","unstructured":"Meng FT, Ma GH, Qiu W, Su ZG. W\/O\/W double emulsion technique using ethyl acetate as organic solvent: effects of its diffusion rate on the characteristics of microparticles. J Control Release. 2003;91(3):407\u201316.","journal-title":"J Control Release"},{"issue":"2","key":"356_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0378-5173(99)00422-6","volume":"196","author":"A Lamprecht","year":"2000","unstructured":"Lamprecht A, Ubrich N, Hombreiro P\u00e9rez M, Lehr C-M, Hoffman M, Maincent P. Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm. 2000;196(2):177\u201382.","journal-title":"Int J Pharm"},{"issue":"1\u20133","key":"356_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0168-3659(97)00106-5","volume":"50","author":"M Zambaux","year":"1998","unstructured":"Zambaux M. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Release. 1998;50(1\u20133):31\u201340.","journal-title":"J Control Release"},{"issue":"1","key":"356_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1081\/PDT-120017517","volume":"8","author":"U Bilati","year":"2003","unstructured":"Bilati U, All\u00e9mann E, Doelker E. Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method. Pharm Dev Technol. 2003;8(1):1\u20139.","journal-title":"Pharm Dev Technol"},{"issue":"10","key":"356_CR20","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1002\/jps.24101","volume":"103","author":"G Abrego","year":"2014","unstructured":"Abrego G, Alvarado HL, Egea MA, Gonzalez-Mira E, Calpena AC, Garcia ML. Design of nanosuspensions and freeze-dried PLGA nanoparticles as a novel approach for ophthalmic delivery of pranoprofen. J Pharm Sci. 2014;103(10):3153\u201364.","journal-title":"J Pharm Sci"},{"key":"356_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejpb.2015.03.027","volume":"93","author":"T Andreani","year":"2015","unstructured":"Andreani T, Miziara L, Lorenz\u00f3n EN, De Souza ALR, Kiill CP, Fangueiro JF, et al. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: interactions with mucin and biomembrane models. Eur J Pharm Biopharm. 2015;93:118\u201326.","journal-title":"Eur J Pharm Biopharm"},{"key":"356_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jchromb.2006.10.045","volume":"848","author":"AA Almeida","year":"2007","unstructured":"Almeida AA, Campos DR, Bernasconi G, Calafatti S, Barros FAP, Eberlin MN, et al. Determination of memantine in human plasma by liquid chromatography\u2013electrospray tandem mass spectrometry: application to a bioequivalence study. J Chromatogr B. 2007;848:311\u20136.","journal-title":"J Chromatogr B"},{"key":"356_CR23","first-page":"1","volume":"231","author":"G Abrego","year":"2015","unstructured":"Abrego G, Alvarado H, Souto EB, Guevara B, Halbaut L, Parra A, et al. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration. Eur J Pharm Biopharm. 2015;231:1\u201310.","journal-title":"Eur J Pharm Biopharm"},{"key":"356_CR24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.colsurfb.2014.10.047","volume":"123","author":"T Andreani","year":"2014","unstructured":"Andreani T, Kiill CP, de Souza ALR, Fangueiro JF, Fernandes L, Doktorovov\u00e1 S, et al. Surface engineering of silica nanoparticles for oral insulin delivery: characterization and cell toxicity studies. Colloids Surf B Biointerfaces. 2014;123:916\u201323.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1\u20132","key":"356_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijpharm.2013.11.025","volume":"461","author":"JF Fangueiro","year":"2014","unstructured":"Fangueiro JF, Andreani T, Egea MA, Garcia ML, Souto SB, Silva AM, et al. Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity. Int J Pharm. 2014;461(1\u20132):64\u201373.","journal-title":"Int J Pharm"},{"issue":"9","key":"356_CR26","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.bbadis.2014.05.025","volume":"1842","author":"I Pedr\u00f3s","year":"2014","unstructured":"Pedr\u00f3s I, Petrov D, Allgaier M, Sureda F, Barroso E, Beas-Zarate C, et al. Early alterations in energy metabolism in the hippocampus of APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis. 2014;1842(9):1556\u201366.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1\u20133","key":"356_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejphar.2012.12.023","volume":"703","author":"A Nagakura","year":"2013","unstructured":"Nagakura A, Shitaka Y, Yarimizu J, Matsuoka N. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer\u2019s disease and effects of donepezil and memantine. Eur J Pharmacol. 2013;703(1\u20133):53\u201361.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"356_CR28","first-page":"1047","volume":"46","author":"H Steuer","year":"2005","unstructured":"Steuer H, Jaworski A, Elger B, Kaussmann M, Keldenich J, Schneider H, et al. Functional characterization and comparison of the outer blood-retina barrier and the blood\u2013brain barrier. IOVS. 2005;46(3):1047\u201353.","journal-title":"IOVS."},{"issue":"1","key":"356_CR29","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.biomaterials.2013.09.063","volume":"35","author":"C Zhang","year":"2014","unstructured":"Zhang C, Wan X, Zheng X, Shao X, Liu Q, Zhang Q, et al. Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer\u2019s disease mice. Biomaterials. 2014;35(1):456\u201365.","journal-title":"Biomaterials"},{"issue":"12","key":"356_CR30","first-page":"1","volume":"37","author":"D Porquet","year":"2015","unstructured":"Porquet D, Andr\u00e9s-Benito P, Gri\u00f1\u00e1n-Ferr\u00e9 C, Camins A, Ferrer I, Canudas AM, et al. Amyloid and tau pathology of familial Alzheimer\u2019s disease APP\/PS1 mouse model in a senescence phenotype background (SAMP8). Age (Omaha). 2015;37(12):1\u201317.","journal-title":"Age (Omaha)"},{"issue":"2","key":"356_CR31","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1208\/s12248-012-9444-4","volume":"15","author":"KK Cheng","year":"2013","unstructured":"Cheng KK, Yeung CF, Ho SW, Chow SF, Chow AHL, Baum L. Highly stabilized curcumin nanoparticles tested in an in vitro blood\u2013brain barrier model and in Alzheimer\u2019s disease Tg2576 mice. AAPS J. 2013;15(2):324\u201336.","journal-title":"AAPS J"},{"issue":"1","key":"356_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2004.05.005","volume":"51","author":"SK Sonkusare","year":"2005","unstructured":"Sonkusare SK, Kaul CL, Ramarao P. Dementia of Alzheimer\u2019s disease and other neurodegenerative disorders\u2014memantine, a new hope. Pharmacol Res. 2005;51(1):1\u201317.","journal-title":"Pharmacol Res"},{"key":"356_CR33","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2147\/IJN.S28481","volume":"7","author":"E Vega","year":"2012","unstructured":"Vega E, Egea MA, Calpena AC, Espina M, Garc\u00eda ML. Role of hydroxypropyl-\u03b2-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA\u2013PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery. Int J Nanomed. 2012;7:1357\u201371.","journal-title":"Int J Nanomed"},{"issue":"1","key":"356_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0168-3659(02)00127-X","volume":"82","author":"SK Sahoo","year":"2002","unstructured":"Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (d, l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 2002;82(1):105\u201314.","journal-title":"J Control Release"},{"key":"356_CR35","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.colsurfb.2015.10.026","volume":"136","author":"A Parra","year":"2015","unstructured":"Parra A, Mallandrich M, Clares B, Egea MA, Espina M, Garc\u00eda ML, et al. Design and elaboration of freeze-dried PLGA nanoparticles for the transcorneal permeation of carprofen: ocular anti-inflammatory applications. Colloids Surf B Biointerfaces. 2015;136:935\u201343.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"356_CR36","first-page":"107","volume":"3","author":"MV Lokhande","year":"2013","unstructured":"Lokhande MV, Kumar Gupta M, Rathod NG. Structural elucidation of process related impurity in memantine hydrochloride bulk drug by GCMS, NMR and IR techniques. Int J Med Pharm Sci. 2013;3(3):107\u201314.","journal-title":"Int J Med Pharm Sci"},{"key":"356_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.colsurfb.2012.12.008","volume":"104","author":"M Gajendiran","year":"2013","unstructured":"Gajendiran M, Gopi V, Elangovan V, Murali RV, Balasubramanian S. Isoniazid loaded core shell nanoparticles derived from PLGA\u2013PEG\u2013PLGA tri-block copolymers: in vitro and in vivo drug release. Colloids Surf B Biointerfaces. 2013;104:107\u201315.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"356_CR38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1023\/A:1012098005098","volume":"14","author":"RN Alyautdin","year":"1997","unstructured":"Alyautdin RN, Petrov VE, Langer K, Berthold A, Kharkevich DA, Kreuter J. Delivery of Loperamide across the Blood\u2013brain barrier with polysorbate 80-coated Polybutylcyanoacrilate nanoparticles. Pharm Res. 1997;14(3):325\u20138.","journal-title":"Pharm Res"},{"issue":"10","key":"356_CR39","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.biomaterials.2007.11.014","volume":"29","author":"L Liu","year":"2008","unstructured":"Liu L, Guo K, Lu J, Venkatraman SS, Luo D, Ng KC, et al. Biologically active core\/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials. 2008;29(10):1509\u201317.","journal-title":"Biomaterials"},{"issue":"4","key":"356_CR40","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00232-015-9778-9","volume":"248","author":"CW Fong","year":"2015","unstructured":"Fong CW. Permeability of the blood\u2013brain barrier: molecular mechanism of transport of drugs and physiologically important compounds. J Membr Biol. 2015;248(4):651\u201369.","journal-title":"J Membr Biol"},{"key":"356_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva C, Pra\u00e7a C, Ferreira R, Santos T, Ferreira L, Bernardino L. Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release. 2016;235:34\u201347.","journal-title":"J Control Release"},{"issue":"6","key":"356_CR42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","volume":"64","author":"LM Ensign","year":"2012","unstructured":"Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64(6):557\u201370. \n                    https:\/\/doi.org\/10.1016\/j.addr.2011.12.009\n                    \n                  .","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"356_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jconrel.2007.01.016","volume":"119","author":"G Mittal","year":"2007","unstructured":"Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MNV. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release. 2007;119(1):77\u201385.","journal-title":"J Control Release"},{"issue":"4","key":"356_CR44","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/jps.21158","volume":"97","author":"DK Sahana","year":"2008","unstructured":"Sahana DK, Mittal G, Bhardwaj V, Kumar MNVR. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using Estradiol as a model drug. J Pharm Sci. 2008;97(4):1530\u201342.","journal-title":"J Pharm Sci"},{"issue":"3","key":"356_CR45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s11095-008-9763-4","volume":"26","author":"DR Kalaria","year":"2009","unstructured":"Kalaria DR, Sharma G, Beniwal V, Ravi Kumar MN. Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats. Pharm Res. 2009;26(3):492\u2013501.","journal-title":"Pharm Res"},{"issue":"3\u20134","key":"356_CR46","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0927-7765(99)00157-5","volume":"18","author":"M Tob\u0131\u0301o","year":"2000","unstructured":"Tob\u0131\u0301o M, S\u00e1nchez A, Vila A, Soriano I, Evora C, Vila-Jato J, et al. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Colloids Surfaces B Biointerfaces. 2000;18(3\u20134):315\u201323.","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"356_CR47","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.nano.2016.12.003","volume":"13","author":"E S\u00e1nchez-L\u00f3pez","year":"2016","unstructured":"S\u00e1nchez-L\u00f3pez E, Ettcheto M, Egea MA, Espina M, Calpena AC, Folch J, et al. New potential strategies for Alzheimer\u2019s disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe\/PS1dE9. Nanomed Nanotechnol Biol Med. 2016;13:1171\u201382.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"356_CR48","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.brainres.2009.11.044","volume":"1312","author":"SL Valles","year":"2010","unstructured":"Valles SL, Dolz-Gaiton P, Gambini J, Borras C, Lloret A, Pallardo FV, et al. Estradiol or genistein prevent Alzheimer\u2019s disease-associated inflammation correlating with an increase PPAR gamma expression in cultured astrocytes. Brain Res. 2010;1312:138\u201344.","journal-title":"Brain Res"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-018-0356-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12951-018-0356-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-018-0356-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T20:37:53Z","timestamp":1553632673000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-018-0356-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["356"],"URL":"https:\/\/doi.org\/10.1186\/s12951-018-0356-z","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"11 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"32"}}